about
Dabigatran approaching the realm of heparin-induced thrombocytopeniaEvaluation of antithrombotic activity of thrombin DNA aptamers by a murine thrombosis model.Warfarin Therapy: Survey of Patients' Knowledge of their Drug Regimen.Managing antiplatelet and anticoagulant drugs in patients undergoing elective ophthalmic surgery.Platelet secretion: From haemostasis to wound healing and beyond.Rivaroxaban for the treatment and prevention of thromboembolic disease.Apixaban Enhances Vasodilatation Mediated by Protease-Activated Receptor 2 in Isolated Rat ArteriesThe Evaluation of Pharmacodynamics and Pharmacokinetics of Anti-thrombin DNA Aptamer RA-36.
P2860
Q26744261-402D72F5-4CFA-42F5-A409-755C3B7BE188Q35239708-0E3C3D5D-2FB2-4511-933C-C23786E19F21Q35564521-03330FD2-B66D-4860-A886-581877AE2064Q38201452-B34A01D3-A344-41BE-A734-59F42EE52237Q38281989-5732C839-5E7B-4D40-B217-6088456D846BQ38522824-28112CF2-4ACC-4C54-8A77-8B8919221AF8Q41037704-BE753250-1BA7-4187-9237-8B09CC056366Q47222078-465F6497-A610-48CD-BC6A-35CB71FBB85B
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A new paradigm shift in antithrombotic therapy.
@en
type
label
A new paradigm shift in antithrombotic therapy.
@en
prefLabel
A new paradigm shift in antithrombotic therapy.
@en
P2093
P2860
P356
P1476
A new paradigm shift in antithrombotic therapy.
@en
P2093
Alex C Spyropoulos
Anita Pudusseri
Raji Shameem
P2860
P356
10.3389/FPHAR.2013.00133
P577
2013-10-21T00:00:00Z